Definitive Contract FA301622C0041
- Not listed
- Embody, Inc. was awarded a $749,603 firm fixed price purchase order from the Department of the Air Force Materiel Command Research Laboratory. The contract is set aside for total small businesses and will fund Embody's research under the Small Business Innovation Research Program Phase II to improve care and operational readiness through developing three-dimensional bioprinted tissue analogs for volumetric muscle loss injuries. As a commercial stage company specializing in collagen-based...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $1.25M Small Business Innovation Research (SBIR) Program Phase II contract to Epibone, Inc., a Jersey City-based regenerative medicine company specializing in advanced tissue engineering and personalized bone reconstruction. Issued on August 28, 2025, with completion targeted for June 1, 2027, this firm fixed-price purchase order is designated as a total small business set-aside. The contract supports development of EB-OC, a next-generation...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Air Force Research Laboratory (AFRL) to Epibone, Inc., a corporate, for-profit organization. The $1,249,628.00 firm-fixed-price contract is focused on validating Epibone's EB-CMF regenerative bone grafts for use in craniofacial surgery, specifically for the maxilla. The research and development work is aimed at providing innovative medical solutions for military personnel suffering from severe bone trauma....
- This federal contract award, with an ID of FA864924P0954, is for the "EPIBONE: SOLUTION TO PROVIDE BONE RECONSTRUCTION DUE TO BATTLEFIELD INJURY" project, awarded to Epibone, Inc., a small business located in Jersey City, New Jersey. The $74,871 firm fixed-price purchase order was awarded on August 16, 2024 under the Small Business Innovation Research (SBIR) Program Phase I by the Air Force Research Laboratory (AFRL), a defense-oriented federal agency. The contract aims to develop...
- <p>This is a Definitive Contract awarded by the Defense Health Agency (DHA) to Epibone, Inc., a for-profit organization, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of an "Injectable Off-the-Shelf Cell-Based Therapy Cartilage Filler" and has a Firm Fixed Price of $999,921.26. The contract was awarded on August 27, 2018, with a completion date of December 26, 2021. The place of performance is Brooklyn, NY 11226, USA.</p>
- This is a $1,298,832.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Protect3D Inc. The contract is for the development of a "PROTECT3D SOLUTION FOR RAPID DELIVERY OF PATIENT-SPECIFIC MSKI BRACING TO DOD NEEDS MEDICAL R AND D". This is a direct-to-Phase II SBIR award, meaning the contractor has previously completed a Phase I effort. The contract is a Firm Fixed Price definitive contract with an ultimate completion date of...
- This is a $74,472 firm fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Matregenix Inc., a minority-owned, self-certified small disadvantaged business manufacturer based in Mission Viejo, California. The contract is part of the Small Business Innovation Research (SBIR) program and is for the development of novel bi-layer biologically-free amino acid nanofiber membranes to enhance dental and craniomaxillofacial surgery outcomes through improved guided bone...
- <p>This is a Firm Fixed Price purchase order contract awarded by the Air Force Research Laboratory (AFRL), a Defense agency, to LS4 Enterprises, LLC, a small business contractor, under the Small Business Innovation Research (SBIR) program. The contract is for SBIR Phase I research titled "PREVENTING IMPACT AND OVERUSE RELATED INJURIES" with a ceiling value of $74,946.00 and a performance period ending on March 15, 2024. The contract was awarded on December 6, 2023.</p>
- The U.S. Air Force Research Laboratory (AFRL) awarded a $1.25 million Phase II Small Business Innovation Research (SBIR) contract to Matregenix Inc., a minority-owned small disadvantaged business based in Mission Viejo, California. This total small business set-aside contract, awarded on July 18, 2025, supports the development of a surge-capable, non-biologic amino acid-based wound-healing matrix designed specifically for rapid trauma care and streamlined military logistics. The contract is...
- This is a $999,999.14 Firm Fixed Price SBIR Phase II contract awarded by the Department of the Army Medical Command to CFD Research Corporation for a project titled "Vascularization of Thick Tissue Constructs for Regenerative Medicine." The contract was set aside for small businesses and is for research and development work on vascularization of thick tissue constructs for regenerative medicine applications. CFD Research Corporation is a small business that provides engineering...
This is a $3,399,572.70 firm fixed-price contract awarded by the U.S. Air Force Research Laboratory (AFRL) to Embody, Inc., a small business, to produce collagen constructs with extraordinary mechanical strength to accelerate the healing of skeletal muscle injuries. The contract is part of the Department of Defense's Small Business Innovation Research (SBIR) program and is a Phase II action. Embody is a commercial-stage company specializing in collagen-based tendon and ligament healing products for the sports medicine market, and has received prior research and development contracts from the Department of Defense, including the AFRL and the Defense Advanced Research Projects Agency, to support its efforts in regenerative medicine and tissue engineering applications. This contract will fund Embody's work to develop innovative biomaterials and biomanufacturing processes for tissue engineering solutions to address volumetric muscle loss injuries, skeletal muscle trauma, and joint repair.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7m | 6/22/22 |